Nippon India Pharma Fund G
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund G
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 10-May-2004
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8365.4
Nippon India Pharma Fund G - Nav Details
Nav Date
: 12-Jun-2026
NAV [Rs.]
: 538.5606
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
:
Nippon India Pharma Fund G- NAV Chart
Nippon India Pharma Fund G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.93 | -0.49 | 4.19 | 4.62 | 4.12 | 21.89 | 12.21 | 19.8 |
| Category Avg | -1.48 | 3.96 | 6.4 | 5.15 | 10 | 23.45 | 13.95 | 14.83 |
| Category Best | -0.02 | 6.29 | 10.67 | 11.79 | 20.13 | 27.28 | 16.38 | 29.32 |
| Category Worst | -2.63 | -0.92 | -0.53 | -2.66 | 1.77 | 19.09 | 10.35 | -1.67 |
Nippon India Pharma Fund G- Latest Dividends
No Records Found
Nippon India Pharma Fund G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.35 | 6406349 | 1,152.63 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.31 | 2783991 | 631.32 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.72 | 4449746 | 580.02 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.16 | 3795054 | 531.68 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 5.80 | 750754 | 500.52 |
| Equity | Apollo Hospitals | Healthcare Services | 5.20 | 548795 | 448.72 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.94 | 1431195 | 339.99 |
| Equity | Medplus Health | Retailing | 3.68 | 3545229 | 317.36 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.43 | 2555745 | 296.46 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.21 | 2117639 | 277.09 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.21 | 946323 | 277.16 |
| Equity | Max Healthcare | Healthcare Services | 2.97 | 2658082 | 256.53 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.56 | 4366909 | 221.09 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.41 | 1364742 | 208.04 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.34 | 913226 | 201.84 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.32 | 1402630 | 200.07 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.31 | 74339 | 199.63 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.09 | 800549 | 180.12 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.06 | 323678 | 177.95 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 1.90 | 1018224 | 163.66 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.81 | 823911 | 156.04 |
| Equity | Syngene Intl. | Healthcare Services | 1.79 | 3501497 | 154.76 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.69 | 318249 | 146.34 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.47 | 746337 | 126.57 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.29 | 3896349 | 111.35 |
| Equity | Fortis Health. | Healthcare Services | 1.19 | 1103889 | 102.49 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.14 | 213659 | 98.03 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.93 | 1058503 | 80.44 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.92 | 1515264 | 79.47 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 0.83 | 230272 | 71.31 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.73 | 1469374 | 62.98 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.63 | 62568 | 54.00 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.45 | 1834924 | 38.47 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.14 | 111738 | 11.74 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,40,030.99
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
